VSee Health (NASDAQ: VSEE) surged 12.02% in premarket trading following the announcement of a $6 million private placement with a single institutional investor and progress in its iDoc telemedicine contracts. The financing, priced at $0.61 per share and warrant, aligns with the stock’s current price and provides critical liquidity for a company with a "WEAK" financial health rating and negative EBITDA. Concurrently, the company reported activating two new hospitals on its iDoc platform, projected to generate $500,000 in annual revenue, and expanding teleradiology services across 21 of 34 hospitals. These developments, combined with plans to pursue federal contracts via FedRAMP authorization and international expansion, signaled operational momentum and revenue growth potential. The dual focus on addressing cash flow challenges and demonstrating contract execution bolstered investor.
Comments
No comments yet